SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence Molecular Sciences (OpenEye)—a business unit of Cadence Design Systems (Nasdaq: CDNS)—announced today that Pfizer Inc. has signed an agreement to extend and ...
Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...
Two separate research teams have unveiled AI systems that could reshape chemistry: one generates millions of plausible molecules, while the other lets chemists plan syntheses using natural language.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results